AIPLA 2016: USPTO is well-functioning despite criticism, says Michelle Lee – World Intellectual Property Review (subscription)

AIPLA 2016: USPTO is well-functioning despite criticism, says Michelle Lee – World Intellectual Property Review (subscription)


World Intellectual Property Review (subscription)

AIPLA 2016: USPTO is well-functioning despite criticism, says Michelle Lee
World Intellectual Property Review (subscription)
The US Patent and Trademark Office (USPTO) is healthy, well-functioning and poised to successfully handle the challenges and opportunities that lie ahead, its director Michelle Lee has claimed. Lee was speaking at the American Intellectual Property Law …
Has the PTAB compromised the integrity of the patent system?IPWatchdog.com

all 3 news articles »

AIPLA 2016: USPTO is well-functioning despite criticism, says Michelle Lee – World Intellectual Property Review (subscription)

AIPLA 2016: USPTO is well-functioning despite criticism, says Michelle – World Intellectual Property Review (subscription)

AIPLA 2016: USPTO is well-functioning despite criticism, says Michelle – World Intellectual Property Review (subscription)


World Intellectual Property Review (subscription)

AIPLA 2016: USPTO is well-functioning despite criticism, says Michelle
World Intellectual Property Review (subscription)
The US Patent and Trademark Office (USPTO) is healthy, well-functioning and poised to successfully handle the challenges and opportunities that lie ahead, its director Michelle Lee has claimed. Lee was speaking at the American Intellectual Property Law …

AIPLA 2016: USPTO is well-functioning despite criticism, says Michelle – World Intellectual Property Review (subscription)

Rexahn Pharma (RNN) Receives USPTO Notice of Allowance for … – StreetInsider.com

Rexahn Pharma (RNN) Receives USPTO Notice of Allowance for … – StreetInsider.com

Rexahn Pharma (RNN) Receives USPTO Notice of Allowance for …
StreetInsider.com
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here. Rexahn Pharmaceuticals, Inc. (NYSE: RNN) …

and more »

Rexahn Pharma (RNN) Receives USPTO Notice of Allowance for … – StreetInsider.com